Public Inspection: CMS: Medicare and Medicaid Programs: Regulation to Require Drug Pricing Transparency

Pre-publication notice of a final rule from the Centers for Medicare and Medicaid Services (CMS) that would require television advertisements of prescription drugs and biological products for which payment is available through Medicare or Medicaid to include the list price of the product to help beneficiaries make informed decisions and reduce costs. The rule will go into effect 60 days after publication of this notice in the Federal Register, which is scheduled for May 10, 2019.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news